scholarly journals Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder

2021 ◽  
Vol 12 ◽  
Author(s):  
Annabelle M. Belcher ◽  
Kelly Coble ◽  
Thomas O. Cole ◽  
Christopher J. Welsh ◽  
Anna Whitney ◽  
...  
Keyword(s):  
Opioid Use Disorder ◽  
Community Treatment ◽  
Successful Implementation ◽  
Opioid Use ◽  
Screening Process ◽  
Detention Center ◽  
Medication Prescription ◽  
Proven Efficacy ◽  
Pass Through ◽  
Buprenorphine Treatment

Over 10 million individuals pass through U.S. detention centers on an annual basis, with nearly two-thirds meeting criteria for drug dependence/abuse. Despite proven efficacy, treatment with medications for opioid use disorder (MOUD) is underutilized in jail settings—a gap that could be addressed using telemedicine. Here we describe a new program of telemedicine-based clinical provision of new/continuing buprenorphine treatment for individuals detained in a rural jail. Implementation objectives were completed between January and August 2020, and patient encounters were conducted between August 2020 and February 2021. We established (i) telemedicine hardware/software capability; (ii) a screening process; (iii) buprenorphine administration methods; (iv) necessary medical release procedures; (v) telemedicine encounter coordination and medication prescription procedures; and (vi) a research platform. Seven incarcerated patients have been treated, two of whom were referred from community treatment. Patients were mostly male (71%), non-Hispanic White (86%), and averaged 33 years old. All patients tested positive for an opioid upon intake and began/continued buprenorphine treatment in the jail. Average time to first MOUD appointment was 9 days and patients were maintained in treatment an average 21 days. Referrals for continuing community treatment were offered to all patients prior to discharge. We report successful implementation of telemedicine MOUD in a rural detention center, with treatment engagement and initiation occurring prior to the high-risk period of discharge. The fact that this program was launched during the height of the pandemic highlights the flexibility of telemedicine-based buprenorphine treatment. Challenges and obstacles to implementation of buprenorphine treatment in a correctional system are discussed.

scholarly journals The Compendium of U.S. jails: creating and conducting research with the first comprehensive contact database of U.S. jails

2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Chelsea M. A. Foudray ◽  
Camille Kramer ◽  
Danielle S. Rudes ◽  
Carolyn Sufrin ◽  
Eliza Burr ◽  
...  
Keyword(s):  
Health Care Services ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Case Examples ◽  
Treatment Practices ◽  
Care Services ◽  
Contact Information ◽  
Conducting Research ◽  
Pass Through ◽  
Policies And Practices

Abstract Background Millions of people pass through U.S. jails annually. Conducting research about these public institutions is critical to understanding on-the-ground policies and practices, especially health care services, affecting millions of people. However, there is no existing database of the number, location, or contact information of jails. We created the National Jails Compendium to address this gap. In this paper, we detail our comprehensive methodology for identifying jail locations and contact information. We then describe the first research project to use the Compendium, a survey assessing jails’ treatment practices for incarcerated pregnant people with opioid use disorder. Results This study sent surveys electronically or in paper form to all 2986 jails in the Compendium, with 1139 surveys returned. We outline the process for using the Compendium, highlighting challenges in reaching contacts through case examples, cataloging responses and non-responses, and defining what counts as a jail. Conclusion We aim to provide tools for future researchers to use the Compendium as well as a pathway for keeping it current. The Compendium provides transparency that aids in understanding jail policies and practices. Such information may help devise interventions to ensure humane, evidence-based treatment of incarcerated people.

Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use Disorder

2021 ◽  
Author(s):  
Alene Kennedy-Hendricks ◽  
Cameron J. Schilling ◽  
Alisa B. Busch ◽  
Elizabeth A. Stuart ◽  
Haiden A. Huskamp ◽  
...  
Keyword(s):  
Opioid Use Disorder ◽  
Health Plans ◽  
Opioid Use ◽  
Buprenorphine Treatment

scholarly journals Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes

2021 ◽  
pp. 1-9
Author(s):  
James B. Anderson ◽  
Stephen A. Martin ◽  
Anne Gadomski ◽  
Nicole Krupa ◽  
Daniel Mullin ◽  
...  
Keyword(s):  
Primary Care ◽  
Clinical Outcomes ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Project Echo ◽  
Buprenorphine Treatment

scholarly journals Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Walter Ling ◽  
Vijay R. Nadipelli ◽  
Arnie P. Aldridge ◽  
Naoko A. Ronquest ◽  
Caitlyn T. Solem ◽  
...  
Keyword(s):  
Opioid Use Disorder ◽  
Opioid Use ◽  
Long Acting ◽  
Buprenorphine Treatment

scholarly journals Advancing the implementation and sustainment of medication assisted treatment for opioid use disorders in prisons and jails

2019 ◽  
Vol 7 (1) ◽  
Author(s):  
Warren J. Ferguson ◽  
Joan Johnston ◽  
Jennifer G. Clarke ◽  
Peter J. Koutoujian ◽  
Kathleen Maurer ◽  
...  
Keyword(s):  
Care Coordination ◽  
Institutional Design ◽  
Medical Condition ◽  
Training Group ◽  
Opioid Use Disorder ◽  
Community Treatment ◽  
Opioid Use ◽  
Treatment Protocols ◽  
Treatment Providers ◽  
Opioid Use Disorders

Abstract Background Opioid use disorder (OUD) is among the most prevalent medical condition experienced by incarcerated persons, yet medication assisted therapy (MAT) is uncommon. Four jail and prison systems partnered with researchers to document their adoption of MAT for incarcerated individuals with opioid use disorders (OUD) using their established treatment protocols. Employing the EPIS (Exploration, Planning, Implementation, and Sustainment) framework, programs report on systematic efforts to expand screening, treatment and provide linkage to community-based care upon release. Results All four systems were engaged with implementation of MAT at the outset of the study. Thus, findings focus more on uptake and penetration as part of implementation and sustainment of medication treatment. The prevalence of OUD during any given month ranged from 28 to 65% of the population in the participating facilities. All programs developed consistent approaches to screen individuals at intake and provided care coordination with community treatment providers at the time of release. The proportion of individuals with OUD who received MAT ranged considerably from 9 to 61%. Despite efforts at all four sites to increase utilization of MAT, only one site achieved sustained growth in the proportion of individuals treated over the course of the project. Government leadership, dedicated funding and collaboration with community treatment providers were deemed essential to adoption of MAT during implementation phases. Facilitators for MAT included increases in staffing and staff training; group education on medication assisted therapies; use of data to drive change processes; coordination with other elements of the criminal justice system to expand care; and ongoing contact with individuals post-release to encourage continued treatment. Barriers included lack of funding and space and institutional design; challenges in changing the cultural perception of all approved treatments; excluding or discontinuing treatment based on patient factors, movement or transfer of individuals; and inability to sustain care coordination at the time of release. Conclusions Adoption of evidence-based medication assisted therapies for OUD in prisons and jails can be accomplished but requires persistent effort to identify and overcome challenges and dedicated funding to sustain programs.

scholarly journals Effects of Interim Buprenorphine Treatment for opioid use disorder among emerging adults

2020 ◽  
Vol 208 ◽  
pp. 107879 ◽  
Author(s):  
Kelly R. Peck ◽  
Taylor A. Ochalek ◽  
Gary J. Badger ◽  
Stacey C. Sigmon
Keyword(s):  
Emerging Adults ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Buprenorphine Treatment

scholarly journals Successful engagement in buprenorphine treatment among hospitalized patients with opioid use disorder and trauma

2020 ◽  
Vol 215 ◽  
pp. 108253
Author(s):  
Elenore P. Bhatraju ◽  
Natasha Ludwig-Barron ◽  
Julian Takagi-Stewart ◽  
Harveen K. Sandhu ◽  
Jared W. Klein ◽  
...  
Keyword(s):  
Opioid Use Disorder ◽  
Hospitalized Patients ◽  
Opioid Use ◽  
Buprenorphine Treatment
Sign in / Sign up

Export Citation Format

Share Document